Equity and Redeemable Noncontrolling Interests - ATM Program (Details) - USD ($)	1 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Subsidiary or Equity Method Investee [Line Items]
Issuance of common stock, net		$ 1,438,000	$ 309,417,000	$ 1,745,000
At-The-Market Program
Subsidiary or Equity Method Investee [Line Items]
Aggregate amount authorized		$ 1,500,000,000
Maximum shares issuable under forward equity sales agreement (in shares)	9,100,000
Forward rate per share (in dollars per share)	$ 34.01
Issuance of common stock, net	$ 308,000,000
At-The-Market Program | Minimum
Subsidiary or Equity Method Investee [Line Items]
Option indexed to issuers equity, term		1 year
At-The-Market Program | Maximum
Subsidiary or Equity Method Investee [Line Items]
Option indexed to issuers equity, term		2 years
2023 At-The-Market Program
Subsidiary or Equity Method Investee [Line Items]
Aggregate amount remaining		$ 1,500,000,000
Maximum shares issuable under forward equity sales agreement (in shares)				9,100,000
2020 ATM Program
Subsidiary or Equity Method Investee [Line Items]
Forward rate per share (in dollars per share)				$ 35.25
ATM Direct Issuances | Common Stock
Subsidiary or Equity Method Investee [Line Items]
Issuance of common stock, net (in shares)		0	0	0